NICOLE SOPTELEAN: Open Payments
NPI 1912410903 · LORAIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 38 payments from 13 companies in 2025. Trend: 2023 $269 · 2024 $325 · 2025 $760
Food & beverage: $744Education: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $328 |
| Novo Nordisk Inc | 1 | $120 |
| PFIZER INC. | 3 | $62 |
| QOL Medical, LLC | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $37 |
| Ferring Pharmaceuticals Inc. | 2 | $35 |
| Lilly USA, LLC | 1 | $30 |
| Ardelyx, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Celltrion USA Inc. | 1 | $17 |
Products named: RINVOQ, SKYRIZI, Wegovy, Sucraid, VELSIPITY, TREMFYA, REBYOTA, OMVOH.
Industry payments across OH — which companies pay providers there.
